<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01438827</url>
  </required_header>
  <id_info>
    <org_study_id>AV-G-02</org_study_id>
    <secondary_id>AV-G-02</secondary_id>
    <nct_id>NCT01438827</nct_id>
  </id_info>
  <brief_title>Avanz Phleum Pratense Maintenance Dose</brief_title>
  <official_title>Avanz Phleum Pratense Maintenance Dose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ALK-Abelló A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ALK-Abelló A/S</source>
  <brief_summary>
    <textblock>
      The purpose of the trial is to evaluate the efficacy of two dosing schedules of Avanz SQ+
      (Standardised Quality) Phleum pratense compared to placebo in subjects with grass pollen
      induced allergic rhinoconjunctivitis with or without asthma.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recording of rhinoconjunctivitis symptoms</measure>
    <time_frame>Daily recordings during the grass pollen season 2012</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Recording of symptomatic allergy medication use</measure>
    <time_frame>Daily recordings during the grass pollen seasons 2012</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">450</enrollment>
  <condition>Allergic Rhinoconjunctivitis</condition>
  <arm_group>
    <arm_group_label>Avanz Phleum pratense 15,000 SQ+</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Avanz Phleum pratense 4,000 SQ+</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Injection with no active grass component</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Avanz Phleum pratense</intervention_name>
    <description>Suspension for Injection, Every 6 weeks for one year</description>
    <arm_group_label>Avanz Phleum pratense 15,000 SQ+</arm_group_label>
    <arm_group_label>Avanz Phleum pratense 4,000 SQ+</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Suspension for Injection, Every 6 weeks for one year</description>
    <arm_group_label>Injection with no active grass component</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A history of grass pollen allergy

          -  Positive skin prick test to grass

          -  Positive Immunoglobulin E test to grass

        Exclusion Criteria:

          -  Other allergies overlapping the grass pollen season

          -  Severe Asthma (defined as a Forced expiratory volume in 1 second (FEV1) below 70 %
             after adequate treatment)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jörg Kleine-Tebbe, PD Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Center for Dermatology, Allergy and Asthma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UntersuchungsZentrum für Dermatologie, Allergologie und Asthma</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2011</study_first_submitted>
  <study_first_submitted_qc>September 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2011</study_first_posted>
  <last_update_submitted>January 20, 2014</last_update_submitted>
  <last_update_submitted_qc>January 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

